U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H20O7
Molecular Weight 372.3686
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TANGERETIN

SMILES

COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C(OC)=C(OC)C(OC)=C3OC

InChI

InChIKey=ULSUXBXHSYSGDT-UHFFFAOYSA-N
InChI=1S/C20H20O7/c1-22-12-8-6-11(7-9-12)14-10-13(21)15-16(23-2)18(24-3)20(26-5)19(25-4)17(15)27-14/h6-10H,1-5H3

HIDE SMILES / InChI

Molecular Formula C20H20O7
Molecular Weight 372.3686
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Tangeretin is an O-polymethoxylated flavone that is found in tangerine and other citrus peels. Its natural role is to strengthen the cell wall and act as a plant's defensive mechanism against disease-causing pathogens. Animal studies have shown the potential fo tangeretin as a therapeutic in a number of conditions including cancers, asthma, CKD, hypercholesterolemia, and Parkinson's disease.

CNS Activity

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P42574
Gene ID: 836.0
Gene Symbol: CASP3
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
In vitro effects of some flavones on human pyruvate kinase isoenzyme M2.
2015-03
Tangeretin ameliorates oxidative stress in the renal tissues of rats with experimental breast cancer induced by 7,12-dimethylbenz[a]anthracene.
2014-09-02
Polyphenols and human health: prevention of disease and mechanisms of action.
2010-11
Antioxidant enrichment and antimicrobial protection of fresh-cut fruits using their own byproducts: looking for integral exploitation.
2010-10
Isolation and identification of polymethoxyflavones from the hybrid Citrus, hallabong.
2010-09-08
Simultaneous determination of flavonoids in different parts of Citrus reticulata 'Chachi' fruit by high performance liquid chromatography-photodiode array detection.
2010-08-05
Evaluation of the effect of lime fruit juice on the anticoagulant effect of warfarin.
2010-07
Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells.
2010-07
Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework.
2010-06-15
Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources.
2010-06-11
The flavonoid tangeretin activates the unfolded protein response and synergizes with imatinib in the erythroleukemia cell line K562.
2010-06
Polymethoxylated flavones, flavanone glycosides, carotenoids, and antioxidants in different cultivation types of tangerines ( Citrus reticulata Blanco cv. Sainampueng) from Northern Thailand.
2010-05-26
Semisynthesis of natural flavones inhibiting tubulin polymerization, from hesperidin.
2010-04-23
Induction of apoptosis in human cervical carcinoma HeLa cells by polymethoxylated flavone-rich Citrus grandis Osbeck (Dangyuja) leaf extract.
2010-03-20
Managing phenol contents in crop plants by phytochemical farming and breeding-visions and constraints.
2010-03-02
Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells.
2010-03
Flavonoids from the stems of Croton caudatus Geisel. var. tomentosus Hook.
2010-02-26
[Study on the contents of flavonoids in Citrus reticulata 'Chachi' from various habitats and different collecting periods].
2010-02
Hepatoprotective effects of flavonoids from shekwasha (Citrus depressa) against D-galactosamine-induced liver injury in rats.
2010
Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.
2009-12-01
Methylation of dietary flavones increases their metabolic stability and chemopreventive effects.
2009-11-18
Fingerprinting alterations of secondary metabolites of tangerine peels during growth by HPLC-DAD and chemometric methods.
2009-09-01
UPLC/Q-TOFMS/MS as a powerful technique for rapid identification of polymethoxylated flavones in Fructus aurantii.
2009-08-15
Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction.
2009-08-13
Simultaneous determination of five bioactive flavonoids in pericarpium Citri reticulatae from china by high-performance liquid chromatography with dual wavelength detection.
2009-08-12
Semisynthesis and antiproliferative evaluation of a series of 3'-aminoflavones.
2009-07-01
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
2009-06-16
[Reparative isolation and purification of flavones from Pericarpium Citri Reticulatae by high-speed counter-current chromatography].
2009-03
Synthesis and biological evaluation of a series of tangeretin-derived chalcones.
2009-01-01
Investigation of heat treating conditions for enhancing the anti-inflammatory activity of citrus fruit (Citrus reticulata) peels.
2008-09-10
Suppressive Effects of Selected Food Phytochemicals on CD74 Expression in NCI-N87 Gastric Carcinoma Cells.
2008-09
Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals.
2008-07-09
Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells.
2008-03-15
Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes.
2008-03-15
Plant polyphenolics as anti-invasive cancer agents.
2008-02
Minerals, phenolic compounds, and antioxidant capacity of citrus peel extract by hot water.
2008-01
Validated reversed phase LC method for quantitative analysis of polymethoxyflavones in citrus peel extracts.
2008-01
Inhibition of oral carcinogenesis by citrus flavonoids.
2008
Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3.
2007-12
Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones.
2007-11
Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?
2007-10
Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells.
2007-10
Antimicrobial activity of wax and hexane extracts from Citrus spp. peels.
2007-09
Biotransformation of polymethoxylated flavonoids: access to their 4'-O-demethylated metabolites.
2007-06
Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways.
2007-06
Quality control and discrimination of pericarpium citri reticulatae and pericarpium citri reticulatae viride based on high-performance liquid chromatographic fingerprints and multivariate statistical analysis.
2007-04-11
Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits.
2007-04
Chemopreventive effects of orange peel extract (OPE). II: OPE inhibits atypical hyperplastic lesions in rodent mammary gland.
2007-03
Chemopreventive effects of orange peel extract (OPE). I: OPE inhibits intestinal tumor growth in ApcMin/+ mice.
2007-03
Suppressive effects of demethylated metabolites of nobiletin on phorbol ester-induced expression of scavenger receptor genes in THP-1 human monocytic cells.
2007
Patents

Sample Use Guides

CKD was induced in Sprague-Dawley rats by 5/6 nephrectomy (Nx). Separated groups of 5/6 Nx rats were treated intragastrically with tangeretin (50, 100 or 200 mg/kg bw) or enalapril for 30 days, starting 5 days after the surgery. Elevated TNF-α, nitric oxide (NO) and cytokines-IL-6 and IL-1β with upregulated NF-κB/TNF-α/iNOS signaling pathways were effectively down-regulated by tangeretin. Cognitive disturbances and memory impairments observed in Nx rats were substantially improved by tangeretin. Collectively, the experimental data indicate that the anti-oxidant and anti-inflammatory effects of tangeretin effectively improved renal function and reduced the cognitive and memory impairments in CKD-induced animals.
Route of Administration: Intragastric
Human colorectal adenocarcinoma cell line, LoVo, and its resistant subline, LoVo/Dx, obtained by prolonged exposure to doxorubicin were cultivated in Ham's F12 medium at 37 deg-C and an atmosphere of 5% CO2 (with addition of 10% fetal bovine serum, L-glutamine, antibiotics, and in the case of loVo/Dx cells, doxorubicin at 100 ng/mL). Cells were seeded in 96-well plates in 75 micro-L of medium and allowed to attach for 60 min at 37 deg-C. An equal volume of medium containing Tangeretin was added, and the incubation was continued for 72 hours. Cytotoxicity was monitored using a sulforhodamine B assay. Tangeretin demonstrated the greatest cytotoxicity among studied compounds in both LoVo, and LoVo/Dx cells with an IC50 range between 20 - 40 microM.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:16:18 GMT 2025
Edited
by admin
on Mon Mar 31 18:16:18 GMT 2025
Record UNII
I4TLA1DLX6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TANGERETIN
WHO-DD  
Common Name English
TANGERITIN
INCI  
INCI  
Preferred Name English
NSC-618905
Code English
Tangeretin [WHO-DD]
Common Name English
FLAVONE, 4',5,6,7,8-PENTAMETHOXY-
Systematic Name English
4H-1-BENZOPYRAN-4-ONE, 5,6,7,8-TETRAMETHOXY-2-(4-METHOXYPHENYL)-
Systematic Name English
5,6,7,8-TETRAMETHOXY-2-(4-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE
Systematic Name English
NSC-53909
Code English
PONKANETIN
Common Name English
4',5,6,7,8-PENTAMETHOXYFLAVONE
Systematic Name English
5,6,7,8,4'-PENTAMETHOXYFLAVONE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C68464
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID30197417
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
FDA UNII
I4TLA1DLX6
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
NSC
53909
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
PUBCHEM
68077
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
NCI_THESAURUS
C68468
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-570-1
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
SMS_ID
300000037347
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
CHEBI
9400
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
MESH
C059006
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
WIKIPEDIA
TANGERITIN
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
CAS
481-53-8
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
DAILYMED
I4TLA1DLX6
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
NSC
618905
Created by admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
48% Cell growth rate of mouse myeloid leukemia M1 cells at 50 uM of compound vs control
PARENT -> CONSTITUENT ALWAYS PRESENT
26% Cell growth rate of human acute promyelocytic leukemia HL-60 cells at 50 uM of compound vs control
TRANSPORTER -> INHIBITOR